Skip to content

What is the functional adult screening tool FAST?

3 min read

According to the Alzheimer’s Association, over 6 million Americans are living with Alzheimer's disease, a condition where progression is often tracked using assessment tools. One such measure is the Functional Assessment Staging (FAST) scale, which is used to evaluate the functional decline in individuals with dementia, most notably Alzheimer's disease.

Quick Summary

The Functional Adult Screening Tool, known as the Reisberg FAST scale, is a clinical assessment used by healthcare professionals to track the progressive stages of functional decline in patients with dementia, primarily Alzheimer's disease, to guide treatment and care planning.

Key Points

  • Dementia Assessment: The most common 'FAST' in senior care is the Reisberg Functional Assessment Staging scale, which tracks functional decline in dementia patients, particularly those with Alzheimer's disease.

  • Seven Stages of Decline: The FAST scale outlines seven distinct stages of dementia progression, from no impairment to very severe decline and total dependence.

  • Focus on Functional Ability: Unlike purely cognitive tests, the FAST scale focuses on a person's ability to perform daily activities, offering a practical metric for monitoring progression.

  • Guiding Care Decisions: By accurately assessing a patient's stage, healthcare providers and families can make informed decisions regarding care plans, interventions, and eligibility for services like hospice care.

  • Not the Only FAST: The acronym FAST is used for several different tools, so clarifying the context is important, especially when dealing with behavioral or aphasia assessments.

  • Empowering Caregivers: The scale provides a predictive roadmap for caregivers, helping them anticipate changes and prepare for increasing levels of support and supervision.

  • Hospice Eligibility: Reaching Stage 7 on the FAST scale is a key indicator for determining hospice eligibility for Alzheimer's patients, contingent on other health criteria.

In This Article

Understanding the Functional Assessment Staging (FAST) Scale

While the acronym FAST can refer to a number of tools, in the context of senior care, it is most frequently associated with the Reisberg Functional Assessment Staging scale. This reliable and widely-used measure provides a clear, stage-by-stage framework for tracking the functional deterioration caused by primary degenerative dementia, such as Alzheimer's disease. Developed by Dr. Barry Reisberg, the tool is a critical resource for healthcare providers, caregivers, and families, helping them understand the disease's progression, plan for future needs, and determine eligibility for specialized care like hospice.

Unlike cognitive tests that primarily focus on memory and thinking skills, the FAST scale emphasizes the ability to perform daily living tasks. This functional focus provides a more practical and direct way to monitor the patient's condition and adapt care strategies as their needs evolve.

The Seven Stages of the FAST Scale

The FAST scale consists of seven main stages, with several sub-stages within the later, more severe phases. This ordinal progression is a key feature, as it suggests that patients with pure Alzheimer's disease typically move through these stages in a linear fashion. The stages describe a progression of functional loss, from no impairment (Stage 1) to very severe decline (Stage 7) where basic abilities are lost. The specific stages detail increasing difficulty with tasks, moving from complex activities in early stages to basic self-care in later stages. Stage 6 involves needing assistance with daily activities like dressing, bathing, and toileting, as well as experiencing incontinence. The final stage, Stage 7, involves the loss of verbal and motor skills, progressing through sub-stages that mark the loss of speech, walking, sitting, smiling, and holding one's head up.

Using the FAST Scale for Hospice Eligibility

One of the most critical applications of the FAST scale is determining eligibility for hospice care, especially for patients with advanced dementia. Individuals in Stage 7 of the FAST scale, combined with other clinical indicators like recurrent infections or significant weight loss, may be deemed eligible for hospice services. While criteria can vary, the FAST scale provides a standardized basis for this important end-of-life care decision.

Comparing the FAST Dementia Scale with Other Assessments

It is important to understand that the Reisberg FAST scale is not the only tool for dementia assessment. Here is a comparison with other common scales:

Feature FAST Scale Mini-Mental State Exam (MMSE) Clinical Dementia Rating (CDR) Scale
Focus Functional abilities for daily living Cognitive functions (memory, orientation, calculation) Global dementia severity (cognition & function)
Disease Progression Tracks functional decline through 7 stages Provides a single score indicating cognitive impairment Assesses cognitive domains and combines into an overall rating
Key Use Staging Alzheimer's disease progression, guiding care planning, determining hospice eligibility Initial screening for cognitive impairment Research and clinical trials for global severity
Who Completes Clinician, caregiver, and/or family member based on observation Clinician administers a series of questions and tasks Physician completes based on interview with patient and informant

Other Functional Screening Tools Called 'FAST'

As mentioned, the acronym FAST is used for other tools, which can cause confusion. Awareness of these is important for healthcare professionals and patients alike to avoid misinterpretation.

  • Functional Assessment Screening Tool (Behavioral): Used to identify environmental and physical factors that may influence problem behaviors.
  • Functional Adult Screening Tool (Cognitive/Language): A non-standardized tool to evaluate a client's cognitive and language skills for functional activities.
  • Frenchay Aphasia Screening Test (FAST): Designed to provide a quick and simple way to identify language deficits in patients with aphasia.

How Caregivers Can Use the FAST Framework

For family caregivers, the Reisberg FAST scale is an invaluable guide. Understanding the current stage and what to expect can help prepare for necessary changes in care, living arrangements, and communication. It aids in communicating effectively with healthcare teams by offering a clear picture of the patient's functional status. Using the scale can also help caregivers focus on providing compassionate care rather than feeling overwhelmed. For more information on navigating dementia care, consult authoritative resources like the Alzheimer's Association.

Conclusion

The Functional Assessment Staging (FAST) scale is a cornerstone of dementia care, offering a reliable, stage-based framework for tracking the progressive functional decline associated with Alzheimer's disease. For seniors and their families, understanding the FAST scale is crucial for proactive care planning, anticipating future needs, and accessing appropriate support at every stage of the disease, including end-of-life hospice care.

Frequently Asked Questions

In senior care, FAST most commonly stands for the Functional Assessment Staging scale. It is a clinical tool used to measure the progression of functional decline in patients with primary degenerative dementia, such as Alzheimer's disease.

The Reisberg Functional Assessment Staging scale was developed by Dr. Barry Reisberg and his colleagues in the 1980s. It provides a standardized and validated measure for tracking the stages of Alzheimer's disease.

The FAST scale is primarily a functional test. While cognitive decline is a component of dementia, this tool specifically measures the progressive loss of functional abilities and daily living skills, rather than focusing solely on memory or thinking skills.

While the FAST scale was designed for Alzheimer's disease, its framework for measuring functional decline can provide insights into other neurodegenerative disorders. However, its accuracy and utility may differ depending on the specific type of dementia, as not all dementias progress through the stages in the same sequence.

For Alzheimer's patients, a FAST scale score in Stage 7 is a primary criterion for determining eligibility for hospice care. This is often combined with other clinical indicators, such as frequent infections, significant weight loss, or difficulty swallowing.

The key difference is their focus. The FAST scale measures functional ability—how a person performs daily tasks—while the Mini-Mental State Examination (MMSE) is a cognitive test that measures memory, orientation, and calculation. Both tools can be used to assess dementia, but they evaluate different aspects of the disease.

A caregiver can use the FAST score to understand the patient's current stage of decline and anticipate future needs. It helps in planning for necessary support, adapting communication, and making informed decisions with healthcare providers about the appropriate level of care. It also provides a shared language for discussing the patient's condition with other professionals.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.